Anadis Opens New Approach to Respiratory Disease Control

kavin submitted, created time 2 months 3 weeks (www.medicalnewstoday.com)

Anadis Limited (ASX: ANX), a research-driven biopharmaceutical company focused on polyclonal antibodies to address human disease, announced important progress concerning its accelerated program to develop a nasal antibody spray to provide immediate post-exposure prophylaxis against a range of influenza viruses.

Working with an animal influenza challenge model in the laboratory of Professor Loreena Brown at the Department of Microbiology and Immunology, University of Melbourne, scientists successfully completed a series of proof-in-principal experiments

3 comments | Blog It | Email It | Keywords: antibodies drug discovery the flu influenza influenza A viruses influenza A virus influenza B virus avian influenza virus

New field-deployable biosensor detects avian influenza virus in minutes instead of days

franklin submitted, created time 1 year 1 month (www.eurekalert.org)

Quick identification of avian influenza infection in poultry is critical to controlling outbreaks, but current detection methods can require several days to produce results. A new biosensor developed at the Georgia Tech Research Institute can detect avian influenza in just minutes. In addition to being a rapid test, the biosensor is economical, field-deployable, sensitive to different viral strains and requires no labels or reagents.

1 comment | Blog It | Email It | Keywords: biosensor avian influenza virus